STOCK TITAN

Plexus Corp SEC Filings

PLXS NASDAQ

Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Plexus Corp.'s SEC filings document operating results, financial condition, governance matters and material corporate events for its complex product design, manufacturing and services business. Recent 8-K reports furnish quarterly and fiscal-year earnings releases and related financial information for the company's product lifecycle operations across regulated end markets.

The filings also record shareholder meeting results, including director elections, advisory executive compensation votes and auditor ratification, as well as officer transition and compensation-arrangement disclosures. These records describe formal governance actions, executive roles and recurring public-company reporting obligations for PLXS.

Rhea-AI Summary

Plexus Corp. executive Oliver K. Mihm, Exec VP & COO, reported equity award activity and a share disposition. On January 30, 2026, 7,280 Restricted Stock Units granted under the Plexus Corp. 2016 Omnibus Incentive Plan vested and settled into an equal number of common shares.

On the same date, 3,455 shares of Plexus common stock were disposed of at $199.33 per share, leaving Mihm with 22,267 shares held directly. In addition, 981 shares of Plexus common stock were held indirectly through the Plexus Corp. 401(k) Retirement Plan as of the plan trustee’s last report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Plexus Corp President & CEO Todd P. Kelsey reported equity award vesting and subsequent share sales. On January 30, 2026, 31,290 restricted stock units converted into the same number of common shares, with 14,724 shares withheld at $199.33 per share, typically to cover taxes.

On February 3, 2026, Kelsey sold several blocks of Plexus common stock, including 3,837 shares at a weighted average price of $204.5332 and 2,163 shares at $205.8826, plus smaller trades at higher prices. After these transactions, he directly owned 78,598 Plexus shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Plexus Corp executive Patrick J. Jermain, Exec. VP & CFO, reported multiple equity transactions in company stock. On January 30, 2026, 9,360 Restricted Stock Units vested and settled into an equal number of Plexus common shares under the company’s 2016 Omnibus Incentive Plan. On the same date, 4,433 shares were surrendered to cover tax obligations at a price of $199.33 per share. On February 3, 2026, he sold 4,841 common shares at $204.01 per share. Following these transactions, he held 20,469 shares directly and 3,719 shares indirectly through the Plexus Corp. 401(k) Retirement Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

A trust named TODD P KELSEY & KELLY M LIV T U/A DTD 03/02/2009 has filed a Form 144 indicating an intent to sell 8,120 common shares of the PLXS issuer through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The planned sale has an stated aggregate market value of 1,669,880.20, with 26,774,415 shares outstanding for the issuer. These shares were acquired as restricted stock from the issuer on 01/25/2024. Over the past three months, the same trust reported selling 2,000 common shares for 290,200.00 on 11/05/2025 and another 2,000 shares for 287,000.00 on 11/04/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Plexus Corp. insider Patrick Jermain has filed a Form 144 notice to sell up to 4,841 shares of Plexus common stock. The planned sale, with an aggregate market value of $987,612.41, is to be executed through Morgan Stanley Smith Barney LLC on or around February 3, 2026 on the NASDAQ market. The shares come from restricted stock acquired on January 25, 2019 and performance shares acquired on November 13, 2024. Over the prior three months, Jermain also sold 2,000 Plexus common shares for gross proceeds of $287,070.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Plexus Corp. investor filed a Form 144 indicating an intent to sell 5,000 shares of common stock. The proposed sale is to be executed through Robert W. Baird & Co. on the NASDAQ, with an aggregate market value of $996,650 for the shares listed in the notice.

The table notes that 26,713,916 shares of Plexus common stock were outstanding, providing context for the planned sale. The 5,000 shares were originally acquired on 11/30/1999 in a transaction involving a Family Trust and David and Constance Foate, with the form listing an approximate sale date of 02/02/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

A shareholder of PLXS has filed a Rule 144 notice to sell 926 shares of common stock, with an aggregate market value of $189,756.01. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 02/02/2026.

The securities were acquired as restricted stock from the issuer on 01/30/2026, and the same date is listed as the payment date. Shares outstanding for this class are reported at 26,774,415, providing context for the relative size of the proposed sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Plexus Corp. filed a current report to share that it has released financial results for its fiscal first quarter ended January 3, 2026. The company announced these results on January 28, 2026 and attached the full earnings press release as an exhibit to the report.

The press release is included as Exhibit 99.1, allowing investors to review detailed information about Plexus Corp.’s operations and financial condition for the quarter. The report itself is primarily a formal notice that these quarterly results have been publicly released.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.26%
Tags
current report
-
Rhea-AI Summary

Plexus Corp. director reports amended stock gift transaction

A Plexus Corp. (PLXS) director reported the bona fide gift of 700 shares of Plexus common stock. After this gift, the director beneficially owns 8,165 shares in direct form. This amendment corrects the transaction date to November 21, 2025, clarifying that an earlier attempted transfer on November 4, 2025 did not go through due to an administrative error and the shares were returned before being successfully transferred on the corrected date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Plexus Corp. (PLXS) executive Oliver K. Mihm, Exec VP & COO, reported several equity transactions in company stock. On 11/12/2025, 5,023 shares of common stock were acquired following the vesting and settlement of performance stock units, while 2,361 shares were disposed of at a price of $146.24 per share, typically reflecting shares withheld or sold to cover taxes. Mihm also made a bona fide gift of 1,100 shares of Plexus common stock.

The filing shows 981 shares of Plexus common stock held indirectly in the company’s 401(k) Retirement Plan. In addition, 1,383 new performance stock units were credited based on company performance. The company disclosed that 138% of the economic return portion of performance stock units granted in fiscal 2023 vested, while the portion tied to relative total shareholder return versus the S&P 400 Index has not yet completed its three-year performance period.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Plexus (PLXS) SEC filings are available on StockTitan?

StockTitan tracks 136 SEC filings for Plexus (PLXS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Plexus (PLXS)?

The most recent SEC filing for Plexus (PLXS) was filed on February 3, 2026.